RE: Markku - on Proactive13 Sep 2018 21:43
Itsallamess, tend to agree in part but that depends on when they found out the issues or if they had managed to fully understand and correct them before the Japan trials were very much underway. We know there has been no extension to the Japan trials to accommodate any revisions since Europe results. Would have been nice to have some form of update on what they think but only 5 weeks to wait. My gut feeling will be they will know the reasons for the failure and it will be easily corrected, Japan will be mixed, and they will start a new batch of patient trials Q4, with a better version of T learning from the Europe and Japan trials. Just opinion, but this is a great company with huge potential if people are patient.